|
시장보고서
상품코드
2084651
임상시험용 생성형 AI 시장 : 구성요소별, 전개 방식별, 용도별, 최종사용자별, 지역별Generative AI in Clinical Trial Market, By Component, By Deployment, By Application, By End User, By Geography |
||||||
임상시험용 생성형 AI 시장 규모는 2026년에 6억 8,540만 달러로 추정되며, 2033년까지 42억 7,680만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 29.9%로 성장할 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 6억 8,540만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 29.90% | 예측 금액(2033년) | 42억 7,680만 달러 |
임상시험용 생성형 AI 시장은 제약 업계의 연구개발 및 의약품 개발 파이프라인의 양상을 재정의하고 있습니다. 생성형 AI는 기계 학습(ML) 및 자연어 처리(NLP) 기능을 활용하여 임상시험 설계와 피험자 모집·선정을 최적화하고, 합성 데이터를 생성하며, 시험 과정을 가속화함으로써 임상시험의 전체 라이프사이클에 걸쳐 업무 효율 향상, 데이터 정확도 개선 및 규제 준수 확보를 실현하고 있습니다.
수요 증가와 의약품 개발 기간 단축 및 승인 건수 증가에 대한 요구로 인해, 제약 및 생명공학 분야 전반에서 생성형 AI에 대한 수요가 높아지고 있습니다. 이러한 분야에서 생성형 AI의 응용 사례로는 프로토콜 최적화, 피험자 계층화, 실세계 증거 생성, 예측 분석, 규제 정보 문서화 등이 있습니다.
시장 역학
세계 임상시험용 생성형 AI 시장은 오랫동안 지속되어 온 의약품 개발 비용의 증가, 복잡성 심화, 그리고 기간의 장기화에 힘입어 성장하고 있습니다. 생성형 AI의 보급에 따라 제약 회사와 생명공학 기업들은 임상시험 설계 최적화, 피험자 모집 촉진, 치료 결과 예측, 그리고 데이터 분석 프로세스의 간소화를 위해 생성형 AI를 점점 더 적극적으로 도입하고 있습니다. 전자건강기록(EHR), 실세계 데이터, 디지털 헬스 데이터 등 데이터 양의 증가는 임상 연구에서 AI의 활용을 더욱 촉진하고 있습니다.
그러나 임상시험용 생성형 AI 시장의 성장은 데이터 개인정보 보호에 대한 우려, AI를 통해 도출된 인사이트에 대한 규제 당국의 승인, 첨단 AI 인프라 도입 비용의 높음과 같은 요인들로 인해 제약을 받고 있습니다. 그렇긴 하지만, 맞춤형 의료, 분산형 임상시험, AI를 활용한 환자 모니터링에서 비롯된 수요의 급증은 시장 성장에 충분한 기회를 가져다줄 것입니다. 임상 연구 업계가 디지털 혁명을 맞이하는 가운데, 생성형 AI는 임상시험의 효율성과 유효성을 높이기 위해 점점 더 중요한 역할을 수행하게 될 것입니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 임상시험용 생성형 AI 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 소개하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 임상시험용 생성형 AI 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 임상시험용 생성형 AI 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 임상시험용 생성형 AI 시장 : 구성요소별(2021-2033년)
제5장 세계의 임상시험용 생성형 AI 시장 : 전개 방식별(2021-2033년)
제6장 세계의 임상시험용 생성형 AI 시장 : 용도별(2021-2033년)
제7장 세계의 임상시험용 생성형 AI 시장 : 최종사용자별(2021-2033년)
제8장 세계의 임상시험용 생성형 AI 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고문헌과 분석 방법
KSM 26.07.16Generative AI in Clinical Trial Market is estimated to be valued at USD 685.4 Mn in 2026 and is expected to reach USD 4,276.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 29.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 685.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 29.90% | 2033 Value Projection: | USD 4,276.8 Mn |
The market for generative AI in clinical trial is redefining research in pharma and its drug development pipeline. Generative AI is speeding up clinical trials by refining the clinical trial design, patient recruitment and selection, producing synthetic data, and accelerating trial processes using its ML and NLP functionalities, thus increasing operational efficiency, improving data accuracy, and ensuring regulatory compliance throughout the lifecycle of a clinical trial.
Due to increasing demand and the need for reduced drug development time and the number of approvals, the demand for generative AI has gone up throughout both pharmaceutical and biotech fields and the application for generative AI in the fields are protocol optimization, patient stratification, generation of real-world evidence, predictive analytics and the documentation of regulatory information.
Market Dynamics
The global generative AI in clinical trial market is driven by increasing cost, complexity, and time for drug development traditionally. With the proliferation of generative AI, the pharmaceutical and biotechnology companies have increasingly adapted to optimize trial designs, enhance patient enrollment, forecast the results of a treatment, and simplify the data analysis part. The growing volume of data, including electronic health records (EHRs), real-world evidence, and digital health data, further enable the use of AI in clinical research.
However, the growth of generative AI in clinical trial market is limited by factors such as data privacy concerns, regulatory approval of the AI derived insights, and a high implementation cost of sophisticated AI infrastructure. Nevertheless, burgeoning demand from personalized medicine, decentralized clinical trials, and AI-driven patient monitoring would bring ample opportunities for market growth. As the clinical research industry undergoes a digital revolution, generative AI will hold a growing place to boost the efficiency and effectiveness of clinical trials.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global generative AI in clinical trial market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medidata Solutions, Unlearn.ai, ConcertAI, Tempus AI, Phesi, AiCure, Lokavant, H1, TrialX, and NetraMark Holdings Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global generative AI in clinical trial market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global generative AI in clinical trial market
Market Segmentation
- Component Insights (Revenue, USD Mn, 2021 - 2033)
- Software Platforms
- Services
- Deployment Insights (Revenue, USD Mn, 2021 - 2033)
- Cloud-Based
- On-Premise
- Appication Insights (Revenue, USD Mn, 2021 - 2033)
- Regulatory Documentation and Medical Writing
- Patient Recruitment and Enrollment
- Clinical Data Management and Analytics
- Protocol Design and Trial Planning
- Pharmacovigilance and Safety Monitoring
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutions
- Healthcare Providers and Clinical Research Centers
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medidata Solutions
- Unlearn.ai
- ConcertAI
- Tempus AI
- Phesi
- AiCure
- Lokavant
- H1
- TrialX
- NetraMark Holdings Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Generative AI in Clinical Trial Market, By Component
- Global Generative AI in Clinical Trial Market, By Deployment
- Global Generative AI in Clinical Trial Market, By Application
- Global Generative AI in Clinical Trial Market, By End User
- Global Generative AI in Clinical Trial Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Generative AI in Clinical Trial Market, By Component, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Software Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Generative AI in Clinical Trial Market, By Deployment, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Generative AI in Clinical Trial Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Regulatory Documentation and Medical Writing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Patient Recruitment and Enrollment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinical Data Management and Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Protocol Design and Trial Planning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pharmacovigilance and Safety Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Generative AI in Clinical Trial Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Healthcare Providers and Clinical Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Generative AI in Clinical Trial Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Deployment, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medidata Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Unlearn.ai
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConcertAI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tempus AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phesi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AiCure
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lokavant
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- H1
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- TrialX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NetraMark Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
